BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10821153)

  • 1. Bisphosphonates: safety and efficacy in the treatment and prevention of osteoporosis.
    Greenspan SL; Harris ST; Bone H; Miller PD; Orwoll ES; Watts NB; Rosen CJ
    Am Fam Physician; 2000 May; 61(9):2731-6. PubMed ID: 10821153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of bisphosphates in treatment of primary and secondary osteoporosis].
    Olszyński WP
    Pol Tyg Lek; 1995 Nov; 50(44-47):56-8. PubMed ID: 8643431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
    Papapoulos SE
    Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
    Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
    Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis.
    Blair MM; Carson DS; Barrington R
    J Fam Pract; 2000 Sep; 49(9):839-48. PubMed ID: 11032210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
    Epstein S
    Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB
    Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials with bisphosphonates.
    Lombardi A; Santora AC
    Ann Ital Med Int; 1992; 7(3 Suppl):158S-165S. PubMed ID: 1297394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy.
    Miller PD
    Clin Ther; 2005 Apr; 27(4):361-76. PubMed ID: 15922811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alendronate: a bisphosphonate for treatment of osteoporosis.
    Kirk JK; Spangler JG
    Am Fam Physician; 1996 Nov; 54(6):2053-60. PubMed ID: 8900364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bisphosphonate therapy in osteoporosis. Inhibition of trabecular perforation by aminobisphosphonate].
    Wüster C; Heilmann P
    Fortschr Med; 1997 Oct; 115(29):37-42. PubMed ID: 9445833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
    Chapurlat R; Meunier PJ
    Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alendronate: a new bisphosphonate for the treatment of osteoporosis.
    Keen RW; Spector TD
    Br J Clin Pract; 1996 Jun; 50(4):211-7. PubMed ID: 8759568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of bisphosphonates in involutional osteoporosis.
    Ott SM
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S597-606. PubMed ID: 8122531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug insight: the use of bisphosphonates for the prevention and treatment of osteoporosis in men.
    Brown SA; Guise TA
    Nat Clin Pract Urol; 2007 Jun; 4(6):310-20. PubMed ID: 17551535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
    Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
    Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.